Taiwan Liposome Company Completes US IPO
Cooley advised Taiwan Liposome Company on its $22.7 million initial public offering of 3,915,550 American Depository Shares – each representing two common shares. Partners Charlie Kim, Robert Phillips, James Lu and David Peinsipp led the Cooley team advising Taiwan Liposome Company.
Cantor acted as book-running manager for the offering. CLSA, HC Wainwright & Co., Janney Montgomery Scott and Laidlaw & Company UK Ltd. acted as book-runners.